CDSCO panel nod to Bajaj Healthcare for Phase III clinical trials of insomnia drug Suvorexant
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok